在重症肌无力（MG）治疗中，为探究 Pyridostigmine 治疗的心脏传导风险，Babol 大学医学科学研究人员对 1 例 62 岁 MuSK 抗体阴性胸腺瘤型 MG 患者进行研究。结果发现该患者因 Pyridostigmine 出现严重房室传导阻滞。这提示临床应重视 MG 亚型诊断及心电监测。 在医学 ...

A sustained-release form of pyridostigmine bromide (Mestinon Timespan) has been in use since 1956. This is a scored, slowly-absorbable tablet containing 180 mg. of pyridostigmine bromide or the ...

Pyridostigmine is used to improve muscle strength in patients with a certain muscle disease (myasthenia gravis). Neostigmine is a medication used to treat myasthenia gravis, Ogilvie syndrome, and ...